CTRI/2018/04/013091
Completed
Phase 3
A Comparative, Randomized, Two Arm, Double Blind, Parallel group, Multicentric Clinical Study to Evaluate the Efficacy, Safety and Tolerability of Ripasudil Hydrochloride Hydrate Eye Drops 0.4% w/v Vs Timolol Maleate Eye Drops 0.5% w/v in Subjects Suffering from Ocular Hypertension / Glaucoma.
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Ocular Hypertension/GlaucomaHealth Condition 2: H408- Other glaucoma
- Sponsor
- Ajanta Pharma Ltd
- Enrollment
- 217
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Subjects with IOP between 22mm Hg â?? 30mm Hg at the time of screening in any one eye. Incase both the eyes of a single subject are affected then the eye fulfilling the criteria will be considered for the evaluations. If both eyes are fulfilling the criteria, then the right eye will be considered for the study.
- •2\.Voluntary willingness of patient to give written informed consent prior to participation in trial.
Exclusion Criteria
- •1\.Women who are not using an effective means of contraception or who are pregnant or nursing.
- •2\.Subjects with any severe or advanced cases of Glaucoma
- •3\.Shaffer angle grade \< 2 in either eye (range, 0 \[complete or partial closure] to 3 \[wide open angle, \> 20]), as measured by Gonioscopy.
- •4\.Subjects who are blind or subjects who have a single eye.
- •5\.Severe central visual field loss in either eye measured by Perimetry.
- •6\.Cup/disc ratio greater than 0\.80\.
- •7\.Subject who are schedule to undergo surgery of the eye during the study period.
- •8\.History of/current chronic, recurrent or severe inflammatory eye disease (eg: scleritis, uveitis, herpes keratitis) or current other severe ocular pathology (including severe dry eye) that would affect the conduct of the study.
- •9\.History of ocular trauma or any other intraocular surgery within the past 6 months in either eye.
- •10\.Current/history of ocular infection or inflammation within the past 3 months as determined by patient history and/or eye examination.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
A study of Netarsudil Ophthalmic Solution 0.02% w/v Vs Timolol Maleate Eye Drops 0.5% w/v in treatment of elevated intraocular pressure in patient with open angle glaucoma or ocular hypertension.Health Condition 1: H401- Open-angle glaucomaCTRI/2020/01/022619Ajanta Pharma Ltd197
Completed
Phase 3
A Clinical Study to Evaluate Efficacy, Safety and Tolerability of Iguratimod Tablets Vs. Methotrexate Tablets for the treatment of Active Rheumatoid Arthritis.Health Condition 1: null- Active Rheumatoid ArthritisHealth Condition 2: E888- Other specified metabolic disordersCTRI/2017/07/009079Ajanta Pharma Ltd244
Recruiting
Not Applicable
A clinical study to assess the safety and effectiveness of two different anti-stretchmark creams in healthy human subjects with complaints of stretchmarks from weight loss or post-pregnancy.CTRI/2023/09/057526Anveya Living Private Limited
Active, not recruiting
Not Applicable
A clinical Study to evaluate the safety and efficacy of Hair Growth Oil and Anti-Gray Hair Oil in Healthy Adult Human Subjects.CTRI/2023/10/058545Keva – S H Kelkar and Company Limited
Completed
Phase 2
Comparative Study to assess efficacy and safety of Mycobacterium W. in Combination with Standard Therapy versus Standard Therapy Alone in treatment of Sepsis.Health Condition 1: null- Sepsis due to Gram Negative InfectionHealth Condition 2: A419- Sepsis, unspecified organismCTRI/2015/07/005961Cadila Pharmaceuticals Limited202